NKTR vs SCHD
Nektar Therapeutics (NKTR) versus SCHD (SCHD) — a side-by-side from cached financials, not a winner call.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
SCHD (SCHD) common stock.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
SCHD does not have a complete income-statement cache yet.
NKTR currently screens at market cap $307.2M. SCHD currently screens at market cap $0.
Not investment advice. Open the NKTR and SCHD stock pages for the full models.
Not investment advice.